BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 15142458)

  • 1. [Diagnostic application of detecting AgNOR in peripheral blood T lymphocyte in patients with esophageal carcinoma].
    Wang JY; Rong TH; Liang YR; Long H; Chen QL; Ma GW
    Ai Zheng; 2004 May; 23(5):577-80. PubMed ID: 15142458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients.
    Mroczko B; Kozłowski M; Groblewska M; Łukaszewicz M; Nikliński J; Jelski W; Laudański J; Chyczewski L; Szmitkowski M
    Clin Chim Acta; 2008 Mar; 389(1-2):61-6. PubMed ID: 18155162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of CEA, SCC and Cyfra21-1 serum test in esophageal cancer].
    Mao YS; Zhang DC; Zhao XH; Wang LJ; Qi J; Li XX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):457-60. PubMed ID: 14575569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma.
    Yamamoto K; Oka M; Hayashi H; Tangoku A; Gondo T; Suzuki T
    Cancer; 1997 May; 79(9):1647-55. PubMed ID: 9128978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of circulating tumor cells in blood by molecular detection and tumor markers in esophageal cancer.
    Nakashima S; Natsugoe S; Matsumoto M; Miyazono F; Nakajo A; Uchikura K; Tokuda K; Ishigami S; Baba M; Takao S; Aikou T
    Surgery; 2003 Feb; 133(2):162-9. PubMed ID: 12605177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
    Guler N; Uckan S; Celik I; Oznurlu Y; Uckan D
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of survival with squamous cell carcinoma antigen in patients with resectable esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Shiratori T; Gunji Y; Kobayashi S; Hayashi H; Ochiai T
    Surgery; 2003 May; 133(5):486-94. PubMed ID: 12773976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Kadomatsu K; Muramatsu T; Ikematsu S; Sakuma S; Ochiai T
    Oncol Rep; 2003; 10(2):411-4. PubMed ID: 12579281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma-antigen messenger RNA level in peripheral blood predicts recurrence after resection in patients with esophageal squamous cell carcinoma.
    Honma H; Kanda T; Ito H; Wakai T; Nakagawa S; Ohashi M; Koyama Y; Valera VA; Akazawa K; Hatakeyama K
    Surgery; 2006 May; 139(5):678-85. PubMed ID: 16701102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of histologic type and smoking status on interpretation of serum carcinoembryonic antigen value in non-small cell lung carcinoma.
    Okada M; Nishio W; Sakamoto T; Uchino K; Yuki T; Nakagawa A; Tsubota N
    Ann Thorac Surg; 2004 Sep; 78(3):1004-9; discussion 1009-10. PubMed ID: 15337038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
    Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
    Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma.
    Morita M; Kuwano H; Matsuda H; Moriguchi S; Sugimachi K
    Cancer Res; 1991 Oct; 51(19):5339-41. PubMed ID: 1913655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M; Kusenda J; Babusíková O
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoembryonic antigen messenger RNA expression in blood predicts recurrence in esophageal cancer.
    Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Ishigami S; Owaki T; Takao S; Aikou T
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5972-7. PubMed ID: 17062668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic value of nucleolar organizer regions in normal epithelium, dysplasia, and squamous cell carcinoma of the oral cavity.
    Xie X; Clausen OP; Sudbö J; Boysen M
    Cancer; 1997 Jun; 79(11):2200-8. PubMed ID: 9179068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma DNA is more reliable than carcinoembryonic antigen for diagnosis of recurrent esophageal cancer.
    Banki F; Yacoub WN; Hagen JA; Mason RJ; Ayazi S; DeMeester SR; Lipham JC; Danenberg K; Danenberg P; DeMeester TR
    J Am Coll Surg; 2008 Jul; 207(1):30-5. PubMed ID: 18589358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the expression of p53, MIB-1 (Ki-67 antigen), and argyrophilic nucleolar organizer regions in carcinoma of the extrahepatic bile duct.
    Suto T; Sugai T; Nakamura S; Funato O; Nitta H; Sasaki R; Kanno S; Saito K
    Cancer; 1998 Jan; 82(1):86-95. PubMed ID: 9428483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.